In cancer cells, VEGF production is up-regulated by mutation in oncogenes, hypoxia establishment and growth factor over-activation, resulting in the “angiogenic switch” [51], characterized by new vasculature formation and exponential growth of the tumor. The gene discussed is VEGFA; the disease is neoplasm.